블로그
- 종의 미래 —아드리안 울프슨 아드리안 울프슨(Adrian Woolfson) ; The co-founder of Genyro, a California-based biotechnology company specialising Darwin Research Fellow at Darwin College, Cambridge, working at the MRC Laboratory of Molecular Biology
- LABU daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology The fund normally creates long positions by investing at least 80% of its assets in the securities that
- [BME] FROM BIOTECHNOLOGY TO BIONANOTECHNOLOGY FROM BIOTECHNOLOGY TO BIONANOTECHNOLOGY Researchers are currently on the edge to broaden biotechnology What is bionanotechnology, and how is it diverse from biotechnology?
